ResMed shares have been caught up in the recent market volatility. Has this created a buying window for ResMed shares?

It’s a great day to be invested in S&P/ASX 200 Index (ASX: XJO) shares today. Here’s why the market is shooting the lights ...

The consensus broker rating on several ASX 200 large-cap shares has just changed amid market turmoil over US tariffs this ...

I’m very bullish about these two ASX shares and think they are appealing opportunities at the current valuations.

In light of the above, the broker has retained its buy rating on the ASX stock with a slightly trimmed price target of $3.00.

You might have noticed that our Australian dollar has taken a hit over the past week. Here are the ASX shares that stand to ...

Here are three ASX growth shares that could be quality picks for Aussie investors after the market selloff. Let's see ...

It’s a banner day for most S&P/ASX 200 Index (ASX: XJO) shares today. Here’s why these five are surging 11% to more than 20%.

Mineral Resources shares have been heavily sold this year, extending steep losses suffered over the past year. Let's dive in.

The broker explains why it has substantially cut its ratings and targets on Viva Energy Group Ltd (ASX: VEA) and Ampol ...

For years I’ve been hearing the lithium price has hit the bottom. Down 80% since 2022's highs, can the lithium price really ...

The ASX share market has jumped. Is it too late to invest in stocks? I’m going to outline a few reasons why I think it’s not ...